Cargando…
Anti-Saccharomyces cerevisiae Antibodies Are Only Modestly More Common in Subjects Later Developing Crohn's Disease
BACKGROUND: The pathogenic processes in the preclinical phase of inflammatory bowel disease (IBD) are mainly unknown. AIMS: To study typical antibodies for IBD in the preclinical phase in a cohort of Northern Sweden. METHODS: Antibodies typical for IBD (ASCA, pANCA, lactoferrin-ANCA, antibodies to g...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905166/ https://www.ncbi.nlm.nih.gov/pubmed/35989383 http://dx.doi.org/10.1007/s10620-022-07630-5 |